[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356339-105":59,"doc-detail-356339-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","spatial-profiling-of-the-metabolism-immune-axis-in-ovarian-cancer","Spatial profiling of the metabolism-immune axis in ovarian cancer","","Ovarian cancer remains highly lethal due to therapeutic resistance shaped by a complex tumor microenvironment coordinated by metabolism–immune crosstalk. This review addresses the spatiotemporal behavior of the metabolism–immune axis across ovarian cancer progression and resistance, emphasizing how cutting-edge spatial multi-omics technologies expose intratumoral heterogeneity and geographic organization beyond bulk assays. Using MALDI-MSI, GeoMx DSP, and CODEX, it maps metabolite gradients, immune niches, and immunometabolic checkpoints, clarifying how localized metabolic rewiring drives immunosuppression and chemoresistance. Spatial insights support location-aware vulnerabilities and inform combination strategies with immune checkpoint inhibitors.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/spatial-profiling-of-the-metabolism-immune-axis-in-ovarian-cancer/356339/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/spatial-profiling-of-the-metabolism-immune-axis-in-ovarian-cancer/356339.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why does ovarian cancer develop strong therapeutic resistance?","Question",{"text":113,"@type":114},"Therapeutic resistance is linked to a complex tumor microenvironment governed by metabolism–immune crosstalk and pronounced intratumoral heterogeneity and spatiotemporal interactions.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What spatial multi-omics tools does the review highlight?",{"text":118,"@type":114},"It highlights MALDI-MSI, GeoMx DSP, and CODEX for high-resolution spatial mapping of metabolite gradients, immune cell niches, and immunometabolic checkpoints.",{"name":120,"@type":111,"acceptedAnswer":121},"How can spatial profiling improve treatment strategies?",{"text":122,"@type":114},"By revealing geographic organization and localized immunosuppression mechanisms, it supports spatially informed therapeutic approaches such as targeting regional metabolic pathways and combining these with immune checkpoint inhibitors.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356339,1790183379,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","TYPE Review  \nPUBLISHED 29 January 2026  \nDOI 10.3389/fphar.2025.1672020  \nOPEN ACCESS  \nEDITED BY  \nBrigida Anna Maiorano,  \nIRCCS Casa Sollievo della Sofferenza Hospital, Italy  \nREVIEWED BY  \nPatricia Talamás-Rohana,  \nNational Polytechnic Institute of Mexico (CINVESTAV), Mexico  \nHaitao Wang,  \nNational Cancer Institute (NIH), United States Anna Fakhardo,  \nThe Pennsylvania State University, United States Sergey Karakashev,  \nTemple University, United States  \n*CORRESPONDENCE  \nZhi-Bin Wang,  \n [wangzhibinwalking@163.com](wangzhibinwalking@163.com)[ ](wangzhibinwalking@163.com)Ma-Sha Huang,  \n [martha0126@163.com](martha0126@163.com)[ ](martha0126@163.com)Zheng Yang,  \n [yangzheng3.15@foxmail.com](yangzheng3.15@foxmail.com)[ ](yangzheng3.15@foxmail.com)Ya-Li Wang,  \n [061032@xxmu.edu.cn](061032@xxmu.edu.cn)[ ](061032@xxmu.edu.cn)RECEIVED 23 July 2025 REVISED 18 December 2025 ACCEPTED 22 December 2025 PUBLISHED 29 January 2026  \nCITATION  \nWang Z-B, Long M-H, Yu P, Wang Y-L, Yang Zand Huang M-S (2026) Spatial profiling of the metabolism-immune axis in ovarian cancer. Front. Pharmacol. 16:1672020 .  \ndoi: 10.3389/fphar.2025.1672020  \nCOPYRIGHT  \n© 2026 Wang, Long, Yu, Wang, Yang and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nSpatial profiling of the metabolism-immune axis in ovarian cancer  \nZhi-Bin Wang 1*, Ming-Hui Long 1, Ping Yu 2, Ya-Li Wang 3*, Zheng Yang 4* and Ma-Sha Huang 4*  \n1Department of Pharmacy, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/ Hunan Cancer Hospital, Changsha, China, 2Department of Pharmacy, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 3Department of Physiology and Pathophysiology, Henan Medical University, Xinxiang, China, 4Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University, School of Medicine, Shanghai, China  \nOvarian cancer remains a lethal disease marked by profound therapeutic resistance, largely orchestrated by a complex tumor microenvironment (TME) governed by metabolism-immune crosstalk. This review focuses on thespatiotemporal dynamics of the metabolism-immune axis in ovarian cancer progression and resistance, with particular emphasis on how cutting-edge spatial multi-omics technologies reveal previously unrecognized layers of intratumoral heterogeneity and geographic organization that cannot be captured by bulk analyses. Using tools such as MALDI-MSI, GeoMx DSP, and CODEX, these approaches enable high-resolution, spatially resolved mapping of metabolite gradients (e.g., lactate, lipids, kynurenine), immune cell niches, and immunometabolic checkpoints within distinct tumor regions. Such spatial profiling uncovers how metabolic reprogramming-dysregulated glycolysis, lipid metabolism, and glutaminolysis-drives localized immunosuppression and chemoresistance through compartment-specific interactions among tumor cells, cancer-associated fibroblasts (CAFs), adipocytes, and immune populations. These geographically defined insights reshape our understanding of therapeutic failure and highlight precise, location-aware vulnerabilities. Accordingly, we propose spatially informed therapeutic strategies, including regional glycolysis inhibition, glutaminase blockade, lipid pathway interference, and their rational combination with immune checkpoint inhibitors (ICIs), to disrupt pathogenic metabolic-immune circuits and improve immunotherapy outcomes. Looking ahead, advances in vivo spatial imaging, gut microbiota","cbCait4SqqsXelRz","https://ap.wps.com/l/cbCait4SqqsXelRz","pdf",4181580,25,"English","# Introduction\n## Spatial profiling of the metabolism–immune axis in ovarian cancer\n## Spatial multi-omics technologies and mapping approaches\n## Therapeutic implications and future directions","[{\"question\":\"Why does ovarian cancer develop strong therapeutic resistance?\",\"answer\":\"Therapeutic resistance is linked to a complex tumor microenvironment governed by metabolism–immune crosstalk and pronounced intratumoral heterogeneity and spatiotemporal interactions.\"},{\"question\":\"What spatial multi-omics tools does the review highlight?\",\"answer\":\"It highlights MALDI-MSI, GeoMx DSP, and CODEX for high-resolution spatial mapping of metabolite gradients, immune cell niches, and immunometabolic checkpoints.\"},{\"question\":\"How can spatial profiling improve treatment strategies?\",\"answer\":\"By revealing geographic organization and localized immunosuppression mechanisms, it supports spatially informed therapeutic approaches such as targeting regional metabolic pathways and combining these with immune checkpoint inhibitors.\"}]","Spatial profiling of the metabolism-immune axis in ovarian cancer | PDF",1790124912,63,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ddb01f7498af5eaefeeb47dd8e5868b.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ccef9cc05dec85bd8117fba1e334122.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11a9e8ae1b1b234233cd420802b41959.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f281223bd8293639e4a0d6cea58d020f.webp",980,1385]